Sign in

CIK 0001799191

  • Accelerated filer
  • Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN STLNW DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843562323
Phone
+1 562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Common stock Nasdaq
  • DFPH Common stock OTC
  1. 4 Grant or award Chief Medical Officer acquired 17,530 shares (grant or award)
  2. 4 Grant or award Chief Operating Officer acquired 70,120 shares (grant or award)
  3. 4 Open-market sale 10% owner sold 8,637 shares at $2.12 ($18,310)
  4. 4 Open-market sale 10% owner sold 43,776 shares at an average $2.21 ($96,835)
  5. 4 Open-market sale 10% owner sold 27,587 shares at an average $2.12 ($58,551)
  6. 4 Other disposition 10% owner disposed of 8,561,048 shares (other)
  7. 4 Grant or award Director acquired 80,000 shares (grant or award)
  8. 4 Grant or award Director acquired 42,652 shares (grant or award)
  9. 4 Grant or award Director acquired 52,000 shares (grant or award)
  10. 4 Grant or award Director acquired 53,326 shares (grant or award)
  11. 4 Grant or award Director acquired 40,000 shares (grant or award)
  12. 4 Grant or award Director acquired 56,000 shares (grant or award)
  13. 4 Grant or award Director acquired 50,000 shares (grant or award)
  14. 4 Grant or award Director acquired 46,630 shares (grant or award)
  15. 4 Open-market buy Chief Financial Officer bought 100,000 shares at an average $1.27 ($126,989)
  16. 4 Grant or award Chief Operating Officer acquired 12,340 shares (grant or award)
  17. 4 Returned to the company Director returned 25,867 shares (to the company)
  18. 4 Returned to the company Chief Executive Officer returned 4,322 shares (to the company)
  19. 4 Returned to the company Chief Medical Officer returned 1,530 shares (to the company)
  20. 4 Open-market sale Director sold 25,000 shares at $2.24 ($56,000)

Page 7 of 14 · 269 filings